Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7015405
Reference Type
Journal Article
Title
Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine
Author(s)
Bose, A; Tsai, J; Li, D; ,
Year
2012
Is Peer Reviewed?
Yes
Journal
Clinical Drug Investigation
ISSN:
1173-2563
Publisher
ADIS INT LTD
Location
AUCKLAND
Volume
32
Issue
6
Page Numbers
373-385
Language
English
PMID
22559255
DOI
10.2165/11631890-000000000-00000
Web of Science Id
WOS:000304727700002
URL
http://
://BCI:BCI201200465787
Exit
Abstract
Comparative evidence for second-step treatment strategies in severe depression is scarce. Up-titrating a well tolerated selective serotonin reuptake inhibitor (SSRI) versus switching to a serotonin norepinephrine reuptake inhibitor (SNRI) after initial SSRI non-response are possible treatment options. It is often unclear whether relevant tolerability and efficacy differences exist between SSRI up-titration versus switch to an SNRI.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity